14 November 2018
According to Alexey Sitalo, president of the Society for Mutual Assistance in Ankylosing Spondylitis, scientists of the N.I. Pirogov Russian National Research Medical University (RNRMU) began trials of the world’s first drug without any side effects for the treatment of an incurable joint disease (Bekhterev’s disease), which affects up to half a million people in the Russian Federation.
Alexey Sitalo, president of the Society for Mutual Assistance in Ankylosing Spondylitis, said:
“Last week, monkey study started. In case all studies yield successful results then in five or six years the drug will be released to the market.”
At the forum of patients with Bekhterev’s disease in Moscow on October 27, RNRMU Rector Sergei Lukyanov said that scientists managed to identify the structures inside the body that allow therapeutic targeting of the inflammatory process.
Existing medicines belong to a different type of drugs, and, in addition, they cause damage to the immune system, resulting in increased susceptibility to disease.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024